Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia 1Graft vs Host Disease 1

Interventions

Methotrexate 48Cyclophosphamide 47Vincristine 39Cytarabine 36Dexamethasone 33Mercaptopurine 32pegaspargase 30Doxorubicin 29Daunorubicin 26Etoposide 24Asparaginase 23Prednisone 22Radiotherapy 18Thioguanine 15Leucovorin 14Calcium Dobesilate 14merphos 12Prednisolone 12blinatumomab 11Hydrocortisone 10Whole-Body Irradiation 9dexamethasone acetate 8azathiopurine 8Methylprednisolone 8Ifosfamide 8Filgrastim 8Cyclosporine 8fludarabine 7dexamethasone 21-phosphate 7auricularum 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Methylprednisolone Acetate × Clear all
NCT00929695 2017-08-21

Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease

Fred Hutchinson Cancer Center

Phase 3 Completed
164 enrolled 19 charts
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡